<DOC>
	<DOCNO>NCT03095885</DOCNO>
	<brief_summary>Identify individual great absorption oxalate base increase urinary oxalate excretion response control oxalate-rich test meal .</brief_summary>
	<brief_title>A Pilot Study Oxalate Absorption Secondary Hyperoxaluria</brief_title>
	<detailed_description>This prospective uncontrolled study subject secondary hyperoxaluria . Subjects visit research center three time outpatient visit ( Screening , Test Day 3 , Day 4 ) . Subjects perform three 24-hour urine collection Screening , Baseline Day 2 , Test Day 3 . Test Day 3 include oxalate-rich test meal subject collect 24-hour urine separate 4 urine collection interval time relation oxalate-rich test meal ( Pre-test meal , 4-hr 6-hr post test meal remain time 24-hours ) .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Hyperoxaluria</mesh_term>
	<criteria>Males nonpregnant nonlactating female History hyperoxaluria secondary know underlie enteric disease ( e.g. , Crohn 's disease , bariatric surgery , others ) without know underlying cause ( idiopathic ) , kidney stone . Urinary oxalate â‰¥ 40 mg oxalate/24hr screening . If take drug prevention stone disease , include pyridoxine , thiazide ( chlorthalidone , hydrochlorothiazide , indapamide ) , citrate supplement , allopurinol , must change medication least one month prior screen change anticipate duration study . Able understand provide write informed consent . Under overcollection screen 24hour urine collection ( mg creatinine/kg body weight outside genderspecific range ) . Estimated glomerular filtration rate ( eGFR ) &lt; 40 mL/minute/1.73 m2 acute renal failure . Primary hyperoxaluria . Allergy , intolerance , factor limit ability consume study food adhere study meal schedule . Positive pregnancy test Screening . Clinically significant finding ( include acute renal colic ) , ongoing clinically significant illness require change management , plan medical/surgical procedure study . Malignancy undergo active therapy ; patient remission chronic suppressive maintenance therapy exclude . Investigational compound within 30 day prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Urine Oxalate</keyword>
	<keyword>Nephrolithiasis</keyword>
	<keyword>Kidney Stones</keyword>
	<keyword>Hyperoxaluria</keyword>
	<keyword>Enteric Hyperoxaluria</keyword>
	<keyword>urological Diseases</keyword>
	<keyword>Kidney Diseases</keyword>
	<keyword>Dietary Oxalate</keyword>
	<keyword>Idiopathic Hyperoxaluria</keyword>
	<keyword>Oxalate Absorption</keyword>
</DOC>